Why Founders are TERRIFIED going after SBIR grants

We need a serious talk about this. Should I skip the SBIR cycle? Does the SBIR backlog help me or bury me? Ever since the SBIR reauthorization has passed, I've been getting flooded with the same questions over and over again from you guys. Should I wait till next year to apply? Is SBIR worth it if I've already raised venture capital? Can foreign investors kill my eligibility? Is the NIH SBIR program really changing the rules? And what is this new $30 million Strategic Breakthrough Award everyone keeps talking about? These aren't small questions, and the answers could actually determine whether your startup gets funded or gets rejected. So I spent the last few weeks digging through the legislations, agency updates, and all the new solicitations to find out what actually changed. And in this video, I'm going to go over the top 10 biggest questions you startup founders are asking me right now and the answers every company needs to know if they're pursuing SBIR funding this year. Starting with number 1: should I skip this SBIR cycle because it's going to be way too competitive? Whatever you do, guys, don't do this. I was shocked when dozens of founders are telling me, maybe I'll sit this cycle out because it's too competitive. And I think that's such a backwards mindset. If anything, waiting can put you in a much more competitive environment. The reality is, is that next year's cycle may be more crowded as agencies work through both new applications and leftover funds from the SBIR/STTR relapse. And at the same time, several new rules, including proposal limits, additional compliance requirements, can make future cycles more restrictive and not less. Let's take the NSF SBIR program, for example. The Project Pitch Portal just reopened. Woo! And now you can test whether or not the agency is interested in your technology with a relatively short submission that takes a fraction of the effort compared to a full proposal. And within a few weeks, you'll have valuable feedback on whether or not you are a good fit for this program. So even if you don't get funded this cycle, the work isn't wasted. The ownership disclosures, foreign risk reviews, commercialization materials, customer validation, and agency relationships you build now become assets that you can reuse in future submissions. Every proposal you prepare today will make your next proposal stronger. And most importantly, SPR funding is non-dilutive. Every time you skip a cycle is a cycle where you're either slowing down your developments or funding the same work by giving away equity. So the founders that I seen who'd win aren't the ones that are just waiting for the perfect cycle or the perfect timing. They're the ones that building momentum early on and stays in the game. If you're on the fence this cycle, my recommendation is do not Wait, get in the pipeline now. Number 2, when can I submit and what is each agency actually doing right now? For the first time in almost a year, the answer is agency-specific instead of we just don't know. The NSF is officially back online, for example, and the project pitch opened on June 2nd. The new 2026 solicitation is live and the next deadline is July 27th. The Department of War is already moving fast. Several 2026 topics are now live, including new DARPA opportunities, and some programs are operating under overlapping funding cycles due to the delays caused by the reauthorization process. Fast. And importantly, in the DOW, new SBIR topics are going to be dropped the first Wednesday of every month. And let's switch gears and talk about NASA, because NASA completely changed its approach. They went from the SBIR program and now moved everything towards the Broad Agency Announcement, or BAA, model. And if you missed the most recent Phase 1 deadline, you'll need to wait for the next batch of subtopics to be released. Now let's talk about the Department of Energy, the DOE, which is expected to reopen very soon with new topics anticipated this summer and deadlines likely falling in the fall. They're also streamlining the process by eliminating the letters of intent requirement and accelerating the transition from Phase 1 to Phase 2. Next up, let's talk about NIH, or the National Institute of Health. The NIH solicitation is opening September 2026 and just released the SBIR and STTR omnibus parent solicitation. The bottom line is this: the SBIR program is back online, but not every agency is moving at the exact same speed. So if you're waiting for the perfect moment when everything is settled and every agency is fully operational, you'll probably be waiting a long time. Number 3: Does the SBIR backlog and rollover from last year help me or bury me? So here's my take: don't assume the relapse reduced competition. If anything, it may have caused trade activity in the next few funding cycles, creating a surge of applications and awards across the entire SBIR ecosystem. Under the Reauthorization Act, agencies can carry unspent SBIR and STTR funds from 2026 into 2027. In other words, the money doesn't disappear, it's going to be rolling forward. And there's also another important consequence: Agencies are now authorized to clear the backlog of applications that were caught in limbo during the relapse. So if you submitted before September 30th, 2025, and were still under review when the SBIR program authority expired, there's a good chance your application is back in motion. But here's where things get quite interesting for everyone else. Those backlog awards, combined with the rollover funding and the new appropriations, actually make 2027 one of the busiest SBIR funding years we've ever seen in a super long time. And that creates two realities at once. Some companies already in the pipeline might see awards moving faster than expected, and at the same time, new applicants could find themselves entering a much more crowded queue. Number 4: Will venture backing weaken my application? I've heard this question all the time from startup founders. We raised venture capital, so SBIR probably isn't for us anymore. Well, newsflash, that's kind of not true. Venture funding and SBIR funding are not mutually exclusive. The key is demonstrating that federal dollars are advancing critical technical risk that private capital alone isn't funding. So having venture backing does not automatically disqualify you from receiving SBIR funds. In fact, a meaningful percentage of SBIR awardees have actually raised outside capital. The real eligibility requirements are still the same. Your company must meet the SBIR ownership requirements and have fewer than 500 employees. That said, venture-backed companies can now face a different question from reviewers. If investors already funded this company, why does it need federal funding too? And the strongest answers I've seen clearly separates the work. Show that your SBIR project is tackling high-risk technical challenges investors aren't paying for yet. The more distinct the R&D effort, easier it is to justify why non-diluted funding is appropriate for you and your startup. Number 5: Do I even qualify and am I the right fit for the program? So most founders assume that the biggest risk is getting a bad score from reviewers. Guess what? It's not. One of the biggest risks is getting screened out before the application ever reaches a review panel. Before you obsess over your NIH-specific aim page or your NSF project pitch responses or your commercialization plan, make sure you clear the administrative hurdles first. And the easiest rejection to avoid is one that should have never ever have happened in the first place. The first trap is the PI employment requirement. Your PI must be primarily employed by the small business upon time of award, mean that more than 50% of the professional efforts must be with the company. And this trips up a lot of university spinouts. The second trap is choosing the wrong program. If your company can perform most of the work independently, maybe the SBIR program is often the right fit. But if a large portion of the research still depends on the university or research institution, then maybe the STTR is a better pathway. And of course, there are administrative mistakes, missing forms, ineligible personnel, registration problems, and budgets that exceed allowable limits. And the harsh reality is that a meaningful number of applicants actually never make it to scientific review because of these issues that have nothing to do with the technology, the innovation, or even your application. Number 6: What is this huge, crazy Strategic Breakthrough Award? And am I a good person to apply for it? When many founders heard about this new Strategic Breakthrough Award, they immediately focused on one number: $30 million. And while that's true, most founders are getting googly-eyed over the completely wrong thing because this SBIR opportunity is only designed for companies. Have already proven their technology and already demonstrated real commercial traction. In other words, this is not like a first-time founder-friendly program. It's a scale-up program. And so to qualify for the Strategic Breakthrough Awards, stars generally need existing Phase II SBIR/STTR award, evidence of commercial viability, and substantial matching funds. In many cases, applicants still need to match federal dollars, making this a much heavier lift than traditional SBIR/STTR funding. And here's another reality check. While the headline number is $30 million, most awards are actually expected to be significantly smaller, likely maybe in the $5 million, $10 million range. At least that's my take and everyone else saying in the space. The other thing founders need to know is that you can't really chase this just yet, and that's because most agencies are still figuring out their implementation plans and the first solicitations aren't expected to hit until late 2026. Number 7, what are the proposal caps and how should that reshape my SBIR strategy? For some years, some companies treated pursuing SBIRs like a number game, you know, like a spray and pray approach. Submit enough proposals, target enough agencies, and eventually something will stick. Well, that's coming to an end. The FAA Reauthorization Act is now requiring agencies to establish limits on how many Phase 1 and Phase 2 proposals a company can submit each year. And these caps can vary by agency and won't take into effect until 2027. But either way, the direction is clear. Agencies want to see quality over quantity, and the winners in this new environment will be the companies submitting the best proposals. That means you now need stronger customer discovery, tighter agency alignment, better compliance, cleaner workshop structures, and importantly, a more thoughtful commercialization strategy around where and when to apply your technology for your short and long-term goal. In other words, stop thinking about the SBIR program like a lottery game and actually be more strategic because each proposal is now becoming an investment of your time and energy, especially when proposal caps arrive. So the companies that have mastered that mindset already will have a huge advantage. Number 8: What do awards actually pay now? A lot of founders have been asking me, what's the maximum budget can I request in my SBIR application? And the answer is no longer as simple as looking up the SBA limits. Yes, they still exist, which can be roughly around $200,000 to $300,000 for a Phase 1 and $1 to $2 million for a Phase 2 before an agency needs a waiver. But don't assume every single federal agency is following the exact same model, because now the difference between a program-wide ceiling and agency-specific ceiling can be hundreds of thousands, or if not even millions of dollars. Take NASA, for example. NASA recently increased its Phase 1 award from $150,000 to $225,000, and its Phase 2 award size from $850,000 to $1.275 million. And that's a substantial increase. And the real budget ceiling isn't always what you think it is. Number 9: Are my existing SBIR awards safe? And what happened during the gap? A lot of founders were worried that if the SBIR program wasn't reauthorized, what would have happened to the existing awards? Would they get frozen? Would they get canceled? Well, guess what? It never happened. If you already have an active Phase I or Phase II award, your funding continues. Agencies kept administrating existing contracts and grants throughout the last— although things have been incredibly slow. The real damage that happened was actually to the pipeline, and this is because new solicitations slowed down. New awards were delayed, and as a result, the number of SBIR and STTR awards dropped significantly last year compared to historic levels. But I want to leave you with one important warning: we're still in a transition period. Many agencies are currently updating the solicitations right now, and implementation guidance is still continuing to evolve. What was true 6 months ago may not be true today. So before you build your timeline, your budgets, or your application strategies, please verify the latest information directly from the agency solicitation and the official program guidance. Number 10: Can I still apply with foreign investors, foreign hires, international IP? If you remember one thing from this video, please make it this: the new foreign risk screening requirements in the SBIR program are no longer a niche compliance issue. They're actually becoming a core eligibility requirement for every applicant. Every application can be evaluated across multiple dimensions, including ownership, investors, licensing agreements, patent rights, employee affiliations, and other foreign relationships. The question no longer is, do you have foreign connections? But now rather the question is, can you clearly explain and document them? And so the startups that prepare early will move through this process much more smoothly than companies that discover these issues at the last minute. Now, before anyone panics, here's the important part. Having foreign connections doesn't automatically make you ineligible. A founder who studies overseas, a European investor, international collaborator, or a company with global ties and operations can still absolutely qualify. The real change is that due diligence is no longer optional. Founders must understand their cap table, their licensing agreements, their international partnerships, and where the technology originated before submitting an application. Don't do this until a problem is discovered by the agency afterwards. So run the foreign audit now. And with that, thank you so much for watching till the end of this video. I hope you found these tips helpful as you work to secure more non-diluted funding for your startup. If you enjoyed this video, please like and subscribe to this channel. It's completely free and gives you new ways to continue learning how to keep your equity throughout your fundraising journey. And also, don't forget to visit our website for more resources, tips, advice, and templates to helping you secure more non-diluted funding. Thank you for joining me today, and I'll see you in a video very soon.